Plus therapeutics enters into master services agreement with piramal pharma solutions, a leading contract development and manufacturing organization

Agreement covers intermediate drug product for rnl™, a radiotherapy in development for several rare cancer targets agreement covers intermediate drug product for rnl™, a radiotherapy in development for several rare cancer targets

PSTV Ratings Summary

PSTV Quant Ranking